Core Viewpoint - The company reported a significant increase in both revenue and profit for the six months ending June 30, 2025, driven primarily by growth in its healthcare solutions segment [1] Financial Performance - Revenue for the period reached 1.495 billion RMB, representing a year-on-year increase of 9.52% [1] - Shareholder profit attributable to the company was 152 million RMB, showing a substantial year-on-year increase of 41.9% [1] - Basic earnings per share were reported at 0.63 RMB [1] - The company proposed an interim dividend of 0.35 HKD per share [1] Revenue Breakdown - Revenue from healthcare solutions increased from 1.345 billion RMB for the six months ending June 30, 2024, to 1.485 billion RMB for the current period, marking a growth of 10.4% [1] - The growth in revenue from healthcare solutions was primarily attributed to the expansion of offline medical institution operations [1]
固生堂(02273)发布中期业绩 股东应占溢利1.52亿元 同比增加41.9%